Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts-Reference-Cited by-同舟云学术

Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts

Published:2007-11-20 Issue:6 Volume:122 Page:1236-1242
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Falchetti Maria Laura,Mongiardi Maria Patrizia,Fiorenzo Paolo,Petrucci Giovanna,Pierconti Francesco,D'Agnano Igea,D'Alessandris Giorgio,Alessandri Giulio,Gelati Maurizio,Ricci-Vitiani Lucia,Maira Giulio,Larocca Luigi Maria,Levi Andrea,Pallini Roberto

Funder

FIRB

Compagnia di San Paolo

Fondi d'Ateneo linea D1

ATENA Onlus

Filas and Fondazione Nando Peretti

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference25 articles.

1. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo;Plate;Nature,1992

2. Evidence for telomerase involvement in the angiogenesis of astrocytic tumors: expression of human telomerase reverse transcriptase messenger RNA by vascular endothelial cells;Pallini;J Neurosurg,2001

3. Glioblastoma induces vascular endothelial cells to express telomerase in vitro;Falchetti;Cancer Res,2003

4. Human endothelial cell life extension by telomerase expression;Yang;J Biol Chem,1999

5. Gadolinium in human glioblastoma cells for gadolinium neutron capture therapy;De Stasio;Cancer Res,2001

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in Telomerase-Targeted Therapies for Glioblastoma: A Systematic Review;International Journal of Molecular Sciences;2024-08-09

2. Premature senescence and cardiovascular disease following cancer treatments: mechanistic insights;Frontiers in Cardiovascular Medicine;2023-09-14

3. Possible molecular mechanisms underlying the development of atherosclerosis in cancer survivors;Frontiers in Cardiovascular Medicine;2023-06-02

4. Telomerase inhibition in malignant gliomas: a systematic review;Expert Reviews in Molecular Medicine;2023

5. Targeting the NCOA3-SP1-TERT axis for tumor growth in hepatocellular carcinoma;Cell Death & Disease;2020-11